Trial Profile
A randomised trial to study the effect of paricalcitol in kidney transplant recipients.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Dec 2015
Price :
$35
*
At a glance
- Drugs Paricalcitol (Primary)
- Indications Secondary hyperparathyroidism
- Focus Therapeutic Use
- 03 Dec 2015 New trial record